Aaron Wealth Advisors LLC Makes New $34,000 Investment in Al

Aaron Wealth Advisors LLC purchased a new position in Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 10,729 shares of the company’s stock, valued at approximately $34,000. Several other hedge funds and other institutional investors have […]

Related Keywords

Canada , , Royal Bank , Victory Capital Management Inc , Mcglone Suttner Wealth Management Inc , Aaron Wealth Advisors , Nasdaq , Ep Wealth Advisors , Exchange Commission , Jpmorgan Chase Co , Allogene Therapeutics Inc , Dorsey Whitney Trust , Allogene Therapeutics , Free Report , Glone Suttner Wealth Management , Capital Management , Whitney Trust , Get Free Report , Visit Holdingschannel , Allogene Therapeutics Daily , Nasdaq Allo , Allo , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,